[1] Odegaard JI, Chawla A. Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis. Science 2013; 339: 172−177. doi: 10.1126/science.1230721 [2]

Laakso M. Is insulin resistance a feature of or a primary risk factor for cardiovascular disease? Curr Diab Rep 2015; 15: 105.

[3] Kurtul BE, Kurtul A, Yalcin F. Predictive value of the SYNTAX score for diabetic retinopathy in stable coronary artery disease patients with a concomitant type 2 diabetes mellitus. Diabetes Res Clin Pract 2021; 177: 108875. doi: 10.1016/j.diabres.2021.108875 [4]

Guerrero-Romero F, Simental-Mendia LE, Gonzalez-Ortiz M, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab 2010; 95: 3347−3351.

[5] Vasques AC, Novaes FS, de Oliveira Mda S, et al. TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study. Diabetes Res Clin Pract 2011; 93: e98−e100. doi: 10.1016/j.diabres.2011.05.030 [6]

Irace C, Carallo C, Scavelli FB, et al. Markers of insulin resistance and carotid atherosclerosis. A comparison of the homeostasis model assessment and triglyceride glucose index. Int J Clin Pract 2013; 67: 665−672.

[7] Xie Y, Guo R, Li Z, et al. Temporal relationship between body mass index and triglyceride-glucose index and its impact on the incident of hypertension. Nutr Metab Cardiovasc Dis 2019; 29: 1220−1229. doi: 10.1016/j.numecd.2019.07.003 [8] Xuan X, Hamaguchi M, Cao Q, et al. U-shaped association between the triglyceride-glucose index and the risk of incident diabetes in people with normal glycemic level: A population-base longitudinal cohort study. Clin Nutr 2021; 40: 1555−1561. doi: 10.1016/j.clnu.2021.02.037 [9] Guo W, Zhu W, Wu J, et al. Triglyceride glucose index is associated with arterial stiffness and 10-year cardiovascular disease risk in a chinese population. Front Cardiovasc Med 2021; 8: 585776. doi: 10.3389/fcvm.2021.585776 [10] Won KB, Lee BK, Park HB, et al. Quantitative assessment of coronary plaque volume change related to triglyceride glucose index: The Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography IMaging (PARADIGM) registry. Cardiovasc Diabetol 2020; 19: 113. doi: 10.1186/s12933-020-01081-w [11] Won KB, Park EJ, Han D, et al. Triglyceride glucose index is an independent predictor for the progression of coronary artery calcification in the absence of heavy coronary artery calcification at baseline. Cardiovasc Diabetol 2020; 19: 34. doi: 10.1186/s12933-020-01008-5 [12] Ding X, Wang X, Wu J, et al. Triglyceride-glucose index and the incidence of atherosclerotic cardiovascular diseases: a meta-analysis of cohort studies. Cardiovasc Diabetol 2021; 20: 76. doi: 10.1186/s12933-021-01268-9 [13]

Mao Q, Zhou D, Li Y, et al. The triglyceride-glucose index predicts coronary artery disease severity and cardiovascular outcomes in patients with non-ST-segment elevation acute coronary syndrome. Dis Markers 2019; 2019: 6891537.

[14] Wang L, Cong HL, Zhang JX, et al. Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome. Cardiovasc Diabetol 2020; 19: 80. doi: 10.1186/s12933-020-01054-z [15] Zhang Y, Ding X, Hua B, et al. High triglyceride-glucose index is associated with adverse cardiovascular outcomes in patients with acute myocardial infarction. Nutr Metab Cardiovasc Dis 2020; 30: 2351−2362. doi: 10.1016/j.numecd.2020.07.041 [16] Luo E, Wang D, Yan G, et al. High triglyceride-glucose index is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention. Cardiovasc Diabetol 2019; 18: 150. doi: 10.1186/s12933-019-0957-3 [17] Luo JW, Duan WH, Yu YQ, et al. Prognostic significance of triglyceride-glucose index for adverse cardiovascular events in patients with coronary artery disease: a systematic review and meta-analysis. Front Cardiovasc Med 2021; 8: 774781. doi: 10.3389/fcvm.2021.774781 [18] Jiao Y, Su Y, Shen J, et al. Evaluation of the long-term prognostic ability of triglyceride-glucose index for elderly acute coronary syndrome patients: a cohort study. Cardiovasc Diabetol 2022; 21: 3. doi: 10.1186/s12933-021-01443-y [19]

Xu H, Li W, Yang J, et al. The China Acute Myocardial Infarction (CAMI) Registry: A national long-term registry-research-education integrated platform for exploring acute myocardial infarction in China. Am Heart J 2016; 175: 193-201 e3.

[20] Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Eur Heart J 2012; 33: 2551−2567. doi: 10.1093/eurheartj/ehs184 [21] American Diabetes A. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2018. Diabetes Care 2018; 41: S13−S27. doi: 10.2337/dc18-S002 [22] Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J 2018; 39: 3021−3104. doi: 10.1093/eurheartj/ehy339 [23] Rabar S, Harker M, O'Flynn N, et al. Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance. BMJ 2014; 349: g4356. doi: 10.1136/bmj.g4356 [24] Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67: 2089−2100. doi: 10.1111/j.1523-1755.2005.00365.x [25] Simental-Mendia LE, Rodriguez-Moran M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord 2008; 6: 299−304. doi: 10.1089/met.2008.0034 [26] Scherrer U, Sartori C. Insulin as a vascular and sympathoexcitatory hormone: implications for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity. Circulation 1997; 96: 4104−4113. doi: 10.1161/01.CIR.96.11.4104 [27] Paolillo S, Rengo G, Pellegrino T, et al. Insulin resistance is associated with impaired cardiac sympathetic innervation in patients with heart failure. Eur Heart J Cardiovasc Imaging 2015; 16: 1148−1153. doi: 10.1093/ehjci/jev061 [28]

Das DK, Engelman RM, Rousou JA, Breyer RH. Aerobic vs anaerobic metabolism during ischemia in heart muscle. Ann Chir Gynaecol 1987; 76: 68−76.

[29]

Stanley WC. Myocardial energy metabolism during ischemia and the mechanisms of metabolic therapies. J Cardiovasc Pharmacol Ther 2004; 9 Suppl 1: S31-S45.

[30] Aroor AR, Mandavia CH, Sowers JR. Insulin resistance and heart failure: molecular mechanisms. Heart Fail Clin 2012; 8: 609−617. doi: 10.1016/j.hfc.2012.06.005 [31] Cooper SA, Whaley-Connell A, Habibi J, et al. Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance. Am J Physiol Heart Circ Physiol 2007; 293: H2009−H2023. doi: 10.1152/ajpheart.00522.2007 [32] Underwood PC, Adler GK. The renin angiotensin aldosterone system and insulin resistance in humans. Curr Hypertens Rep 2013; 15: 59−70. doi: 10.1007/s11906-012-0323-2 [33] Creager MA, Luscher TF, Cosentino F, Beckman JA. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I. Circulation 2003; 108: 1527−1532. doi: 10.1161/01.CIR.0000091257.27563.32 [34] Trifunovic D, Stankovic S, Sobic-Saranovic D, et al. Acute insulin resistance in ST-segment elevation myocardial infarction in non-diabetic patients is associated with incomplete myocardial reperfusion and impaired coronary microcirculatory function. Cardiovasc Diabetol 2014; 13: 73. doi: 10.1186/1475-2840-13-73 [35] Song C, Fu R, Yang J, et al. The association between body mass index and in-hospital outcome among patients with acute myocardial infarction-insights from China Acute Myocardial Infarction (CAMI) registry. Nutr Metab Cardiovasc Dis 2019; 29: 808−814. doi: 10.1016/j.numecd.2019.04.001 [36] Kalantar-Zadeh K, Block G, Horwich T, Fonarow GC. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol 2004; 43: 1439−1444. doi: 10.1016/j.jacc.2003.11.039